• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用富马酸二甲酯治疗的多发性硬化症患者带状疱疹感染时CD4⁺:CD8⁺比值较高。

High CD4+:CD8+ ratios with herpes zoster infections in patients with multiple sclerosis on dimethyl fumarate.

作者信息

Balshi Alexandra, Saart Emma, Pandeya Sarbesh, Dempsey John, Baber Ursela, Sloane Jacob A

机构信息

Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA.

出版信息

Mult Scler. 2023 Oct;29(11-12):1465-1470. doi: 10.1177/13524585231189641. Epub 2023 Aug 12.

DOI:10.1177/13524585231189641
PMID:37572049
Abstract

BACKGROUND

Dimethyl fumarate (DMF) depletes CD8+ and CD4+ T cells, and cases of herpes zoster (HZ) in patients with multiple sclerosis (MS) on DMF have been documented.

OBJECTIVES

To evaluate lymphocyte subsets in patients with MS who developed HZ on DMF (Tecfidera) compared to matched controls who did not develop HZ.

METHODS

We used linear mixed-effects models to test for differences in white blood cell count, lymphocyte percentage, absolute lymphocyte count, CD3+ percentage, absolute CD3+ count, CD4+ percentage, absolute CD4+ count, CD8+ percentage, absolute CD8+ count, and CD4+:CD8+ ratio over time in HZ and non-HZ groups.

RESULTS

Eighteen patients developed HZ while on DMF. The linear mixed-effects model for CD4+:CD8+ ratio showed a significant difference between the HZ and non-HZ groups ( = 0.033). CD4+:CD8+ ratio decreased over time in the HZ group and increased over time in the non-HZ group.

CONCLUSION

Patients with MS who develop HZ while on DMF have high CD4+:CD8+ ratios, suggesting an imbalance of CD4+ and CD8+ cells that may put a patient at risk for developing HZ while on DMF. This result emphasizes the need for lymphocyte subset monitoring (including CD4+:CD8+ ratios) on DMF, as well as vaccination prior to DMF initiation.

摘要

背景

富马酸二甲酯(DMF)会消耗CD8 +和CD4 + T细胞,并且已经有文献记载了使用DMF治疗的多发性硬化症(MS)患者发生带状疱疹(HZ)的病例。

目的

评估在使用DMF(特立氟胺)治疗期间发生HZ的MS患者与未发生HZ的匹配对照组患者的淋巴细胞亚群。

方法

我们使用线性混合效应模型来测试HZ组和非HZ组中白细胞计数、淋巴细胞百分比、绝对淋巴细胞计数、CD3 +百分比、绝对CD3 +计数、CD4 +百分比、绝对CD4 +计数、CD8 +百分比、绝对CD8 +计数以及CD4 +:CD8 +比值随时间的差异。

结果

18例患者在使用DMF期间发生了HZ。CD4 +:CD8 +比值的线性混合效应模型显示HZ组和非HZ组之间存在显著差异(P = 0.033)。HZ组中CD4 +:CD8 +比值随时间下降,而非HZ组中该比值随时间增加。

结论

在使用DMF期间发生HZ的MS患者具有较高的CD4 +:CD8 +比值,这表明CD4 +和CD8 +细胞失衡,这可能使患者在使用DMF时发生HZ的风险增加。这一结果强调了在使用DMF时监测淋巴细胞亚群(包括CD4 +:CD8 +比值)以及在开始使用DMF之前进行疫苗接种的必要性。

相似文献

1
High CD4+:CD8+ ratios with herpes zoster infections in patients with multiple sclerosis on dimethyl fumarate.使用富马酸二甲酯治疗的多发性硬化症患者带状疱疹感染时CD4⁺:CD8⁺比值较高。
Mult Scler. 2023 Oct;29(11-12):1465-1470. doi: 10.1177/13524585231189641. Epub 2023 Aug 12.
2
Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.二甲基富马酸治疗反应的特点是 MS 患者 CD8+T 细胞不成比例减少。
Mult Scler. 2018 Apr;24(5):632-641. doi: 10.1177/1352458517703799. Epub 2017 Apr 24.
3
Delayed lymphocyte re-population following discontinuation of dimethyl fumarate and after switching to other disease modifying drug therapies.停用二甲基富马酸并切换至其他疾病修正药物治疗后,淋巴细胞恢复延迟。
Mult Scler Relat Disord. 2017 Nov;18:60-64. doi: 10.1016/j.msard.2017.09.014. Epub 2017 Sep 21.
4
Worsening of lymphopenia in patients with multiple sclerosis when switched from dimethyl fumarate to diroximel fumarate.多发性硬化症患者从富马酸二甲酯换用富马酸二罗昔迈尔时淋巴细胞减少症恶化。
Mult Scler Relat Disord. 2024 Sep;89:105737. doi: 10.1016/j.msard.2024.105737. Epub 2024 Jun 27.
5
Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.富马酸二甲酯可选择性减少多发性硬化症患者的记忆性T细胞。
Mult Scler. 2016 Jul;22(8):1061-1070. doi: 10.1177/1352458515608961. Epub 2015 Oct 12.
6
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study.接受富马酸二甲酯治疗的多发性硬化症患者 NK 细胞计数增加:一项为期 2 年的纵向研究。
Front Immunol. 2019 Jul 19;10:1666. doi: 10.3389/fimmu.2019.01666. eCollection 2019.
7
Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count.富马酸二甲酯诱导 B 淋巴细胞和 T 淋巴细胞功能改变,与淋巴细胞绝对计数无关。
Mult Scler. 2018 May;24(6):728-738. doi: 10.1177/1352458517707069. Epub 2017 May 8.
8
Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice.富马酸二甲酯对 RRMS 淋巴细胞的影响:对临床实践的启示。
Neurology. 2019 Apr 9;92(15):e1724-e1738. doi: 10.1212/WNL.0000000000007262. Epub 2019 Mar 27.
9
Increased multiple sclerosis disease activity in patients transitioned from fingolimod to dimethyl fumarate: a case series.从芬戈莫德转换为富马酸二甲酯的多发性硬化症患者疾病活动度增加:病例系列研究。
BMC Neurol. 2021 Feb 2;21(1):48. doi: 10.1186/s12883-021-02058-2.
10
Effects of dimethyl fumarate on lymphocyte subsets.富马酸二甲酯对淋巴细胞亚群的影响。
Mult Scler Relat Disord. 2015 Jul;4(4):339-41. doi: 10.1016/j.msard.2015.06.002. Epub 2015 Jun 10.

引用本文的文献

1
Herpes Zoster Infections With Multiple Sclerosis Disease-Modifying Therapies: A Real-World Pharmacovigilance Study.使用多发性硬化症疾病修正疗法时的带状疱疹感染:一项真实世界药物警戒研究。
Neurol Clin Pract. 2025 Apr;15(2):e200462. doi: 10.1212/CPJ.0000000000200462. Epub 2025 Mar 11.
2
Atypical disseminated herpes zoster infections in patients with demyelinating disease treated with dimethyl fumarate.接受富马酸二甲酯治疗的脱髓鞘疾病患者中的非典型播散性带状疱疹感染。
J Neurovirol. 2024 Dec;30(5-6):556-558. doi: 10.1007/s13365-024-01230-x. Epub 2024 Oct 21.
3
CD4/CD8 Ratio: An Independent Predictor of Herpes Zoster in Patients With Autoimmune Inflammatory Rheumatic Diseases.
CD4/CD8 比值:自身免疫性炎性风湿性疾病患者带状疱疹的独立预测指标
Ann Dermatol. 2024 Jun;36(3):163-171. doi: 10.5021/ad.23.126.
4
Reactivation of Herpes Zoster in a Young Patient With Multiple Sclerosis Under Dimethyl Fumarate Treatment and Normal Lymphocyte Subsets Count: A Case Report.富马酸二甲酯治疗且淋巴细胞亚群计数正常的年轻多发性硬化症患者发生带状疱疹再激活:一例报告
Cureus. 2023 Dec 31;15(12):e51412. doi: 10.7759/cureus.51412. eCollection 2023 Dec.